Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 7:40 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 337–360 of 4,558 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: obesity Clear all

Conditions: Post-COVID Conditions, Obesity
Interventions: 12-weeks of Weight Loss, 12-weeks of Weight Stability; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: Up to 80 Years
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2029
U.S. locations: 2
States / cities: Baltimore, Maryland • San Antonio, Texas

Conditions: Healthy
Interventions: Routine Dinner, Late dinner; Dietary Supplement
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 30 Years
Enrollment: 34 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Obesity
Interventions: hypocaloric, low-fat diet; Behavioral
Lead sponsor: The Miriam Hospital; Other
Eligibility: 21 Years to 70 Years · Female only
Enrollment: 147 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2007
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Impulsivity, Compulsive Overeating, Obesity
Interventions: Device: Active Transcranial Direct Current Stimulation (tDCS) coupled with cognitive training, Device: Sham Transcranial Direct Current Stimulation (tDCS) coupled with cognitive training; Device
Lead sponsor: Minneapolis Veterans Affairs Medical Center; Federal
Eligibility: 18 Years and older
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Obesity, Major Depressive Disorder, Dysthymic Disorder, Cardiovascular Disease
Interventions: Behavior Modification for Weight Loss, Alternative Approach to Weight Loss, Cognitive-Behavior Therapy for Depression, Depression Support and Education; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 70 Years
Enrollment: 76 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Cardiomyopathy
Interventions: Not listed
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 35 Years to 65 Years
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Obesity, Induction of Labor Affected Fetus / Newborn
Interventions: Cefazolin, Placebo, Azithromycin; Drug
Lead sponsor: University of Oklahoma; Other
Eligibility: 15 Years to 45 Years · Female only
Enrollment: 186 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Diabetes Mellitus, Type 2
Interventions: Medical Nutrition Therapy; Behavioral
Lead sponsor: The University of Texas Medical Branch, Galveston; Other
Eligibility: 18 Years and older
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Galveston, Texas

Conditions: Healthy, Pregnancy
Interventions: Not listed
Lead sponsor: Arkansas Children's Hospital Research Institute; Other
Eligibility: 21 Years and older · Female only
Enrollment: 320 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2024
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Weight Management
Interventions: ASC30, Placebo; Drug · Other
Lead sponsor: Ascletis Pharma (China) Co., Limited; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 72 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Obesity, Weight Loss, Sedentary Lifestyle
Interventions: Weight loss, Exercise, Sitless; Behavioral
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 65 Years to 85 Years
Enrollment: 183 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Type 2 Diabetes Mellitus
Interventions: Ursodiol; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 70 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Epidural Anesthesia, Spinal Ultrasound, Obesity
Interventions: Palpation, Ultrasound; Procedure · Device
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 19 Years to 45 Years · Female only
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2021
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Obesity
Interventions: Glucagon, Placebo; Drug
Lead sponsor: AdventHealth Translational Research Institute; Other
Eligibility: 18 Years to 55 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2027
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Wound Complications, Wound Infection, Wound Separation
Interventions: Prospective wound complication protocol; Procedure
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 89 Years · Female only
Enrollment: 105 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Feeding and Eating Disorders
Interventions: GT-001; Drug
Lead sponsor: Gila Therapeutics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: Tustin, California

Conditions: Physical Activity, Exercise, Body Composition
Interventions: Mentoring to be Active plus Family, Tracking Health and Fitness; Behavioral
Lead sponsor: Ohio State University; Other
Eligibility: 11 Years and older
Enrollment: 58 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Type 2 Diabetes, BMI Greater Than 30
Interventions: 31P-MRS and MRI; Radiation
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 45 Years to 75 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Type 2 Diabetes
Interventions: Liraglutide; Drug
Lead sponsor: Temple University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2023
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Obesity, Childhood
Interventions: Control Breakfast Beverage, Omega-3 Breakfast Beverage; Dietary Supplement
Lead sponsor: University of Arkansas, Fayetteville; Other
Eligibility: 8 Years to 12 Years
Enrollment: 27 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016
U.S. locations: 1
States / cities: Fayetteville, Arkansas

Conditions: Obesity
Interventions: In-Person weight loss, FIT weight loss, FIT-BT weight loss; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 21 Years to 55 Years
Enrollment: 39 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Childhood Obesity
Interventions: Newsletters, Family-based Telehealth Intervention; Behavioral
Lead sponsor: Indiana University; Other
Eligibility: 5 Years to 11 Years
Enrollment: 41 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Hypertension, Insulin Resistance, Metabolic Syndrome
Interventions: Olmesartan medoxomil, Losartan potassium, Atenolol; Drug
Lead sponsor: Daiichi Sankyo; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2005
U.S. locations: 10
States / cities: Birmingham, Alabama • San Diego, California • Miami, Florida + 7 more

Conditions: Gastric Bypass Surgery, Obesity
Interventions: gastric bypass surgery, Diet induced weight loss; Procedure · Other
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 21 Years to 60 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2010
U.S. locations: 1
States / cities: New York, New York

Search by objective public record fields.

Modifying Adiposity Through Behavioral Strategies to Improve COVID-19 Rehabilitation

Effect of Late Dinner on Nocturnal Metabolism

Changes in Food Reinforcement During Obesity Treatment

tDCS for Impulsivity and Compulsivity in Obesity

Treatment for Depressed, Obese Individuals at Risk for Cardiovascular Disease (CVD)

Reversal of Obesity Cardiomyopathy

Antibiotic Prophylaxis to Prevent Obesity-Related Induction Complications in Nulliparae at Term

Promoting Intergenerational Health in Rural Kentuckians With Diabetes (PIHRK'D)

Fetal Programming of Obesity

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of ASC30 Tablets and ASC30 Tablets A1 in Participants With Obesity

Empowered With Movement to Prevent Obesity and Weight Regain

Ursodiol on Insulin Sensitivity, Gastric Emptying and Body Weight With Type 2 Diabetes on Metformin

Utility of Ultrasound in Identification of Midline and Placement of Epidural in Severely Obese Parturients

Effect of Prolonged (72 Hour) Glucagon Administration on Energy Expenditure in Healthy Obese Subjects

A Study to Evaluate a Quality Improvement Intervention to Reduce Wound Separation Rates in Obese Gynecologic Oncology Service Patients Undergoing Abdominal Surgery

A Dose Escalating Study to Assess the Safety and Tolerability of GT-001

Mentoring to be Active for Rural Appalachia Children

Imaging in Semaglutide Study

Effects of Liraglutide on ER Stress in Obese Patients With Type 2 Diabetes

Nutrition Intervention to Measure Metabolic Response in Children

Comparison of a Technology-based System and an In-person Behavioral Weight Loss Intervention in the Severely Obese

A Theory Driven, Rurally Tailored, Family-Based, Telehealth Intervention for Childhood Obesity

A Comparison of the Effect of Olmesartan Medoxomil, Losartan Potassium, and Atenolol on the Ability of Overweight Patients With High Blood Pressure to Respond to Insulin

Mechanisms of Diabetes Control After Weight Loss Surgery